On Thursday, November 9, 2017, at 12:00pm CT, David Bernard, Joshua James, and Andrew McElligott, attorneys with Brinks' Post-Grant Patent and Medical Device practice groups, presented the webinar, "Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings." Jason Schigelone served as moderator.

Some of the topics discussed include:

• How joinder may delay the issuance of final written decisions, and strategies for avoiding delay
• In re Aqua and its impact on amendment practice in post-grant proceedings
• Article III standing to appeal PTAB decisions to the Federal Circuit